Gliknik Inc. (Gliknik)

HQ Location

801 W. Baltimore Street, Suite 501A
Baltimore, MD 21201

Company Description

Gliknik is creating new therapies for patients with cancer and immune disorders. In September 2013 Gliknik announced a significant license of GL2045, a functional recombinant mimetic of pooled human IVIG, to Pfizer Inc.